E225-0139 Screening compound: N-cyclohexyl-2-(4-ethoxyphenyl)-6-methyl-4-oxo-5-[3-(propan-2-yloxy)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

E225-0139 Screening compound: N-cyclohexyl-2-(4-ethoxyphenyl)-6-methyl-4-oxo-5-[3-(propan-2-yloxy)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide
E225-0139 Screening compound: N-cyclohexyl-2-(4-ethoxyphenyl)-6-methyl-4-oxo-5-[3-(propan-2-yloxy)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E225-0139
N-cyclohexyl-2-(4-ethoxyphenyl)-6-methyl-4-oxo-5-[3-(propan-2-yloxy)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E225-0139

Molecular Formula

C28H40N4O4 (C28 H40 N4 O4)

Compound Name

N-cyclohexyl-2-(4-ethoxyphenyl)-6-methyl-4-oxo-5-[3-(propan-2-yloxy)propyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

IUPAC name

N-cyclohexyl-2-(4-ethoxyphenyl)-6-methyl-4-oxo-5-[3-(propan-2-yloxy)propyl]-4H5H6H7H-pyrazolo[15-a]pyrazine-6-carboxamide

SMILES

CCOc(cc1)ccc1-c1nn(CC(C)(C(NC2CCCCC2)=O)N(CCCOC(C)C)C2=O)c2c1

InChI

InChI=1S/C28H40N4O4/c1-5-35-23-14-12-21(13-15-23)24-18-25-26(33)31(16-9-17-36-20(2)3)28(4,19-32(25)30-24)27(34)29-22-10-7-6-8-11-22/h12-15,18,20,22H,5-11,16-17,19H2,1-4H3,(H,29,34)/t28-/m0/s1

InChI Key

ZMQXQWAIOBWUCK-NDEPHWFRSA-N

MDL Number (MFCD)

MFCD27598541

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

496.65

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.607

Distribution Coefficient, logD

4.607

Water Solubility, LogSw

-4.21

Polar Surface Area

67.773

Acid Dissociation Constant (pKa)

14.81

Base Dissociation Constant (pKb)

3.20

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

60.70

E225-0139 in Drug Discovery

Included in Screening Libraries

Cyclic Ugi PPI Library (9586 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Developmental Pathway (Hh/Wnt) Set (2238 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Others

References: we are preparing a list of scientific research reports with E225-0139 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E225-0139?
Check Price and Availability of E225-0139, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E225-0139 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E225-0139
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E225-0139
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E225-0139 available by request